EIN 20-1624945

Xenobe Research Institute

IRS 501(c) type
501(c)(3)
Num. employees
0
Year formed
2004
Most recent tax filings
2024-06-01
Description
Xenobe Research Institute conducts research on natural and synthetic small molecule therapeutics with the aim to discover and translate new materials for clinical trials. Their mission is to develop molecular probes for large immunophilins that can be targeted clinically. They received funding from Varigen Biosciences / Terra Bioworks to support their small molecule isolation and structure elucidation efforts. Two programs were completed using these funds, covering research supplies, instrument time, and equipment access. The institute is located in San Diego, CA.
Total revenues
$61,315
2024
Total expenses
$147,500
2024
Total assets
$228,101
2024
Num. employees
0
2024

Program areas at Xenobe Research Institute

National Institutes of Health Grant R21NS128597. While well established as clinical targets, the lack of molecular probes to the large immunophilins continues to inhibit our ability to evaluate and drug them clinically. This program explores the development of a general platform to discover probes that target specific domains within a neurological protein. Using cyclophilin 40 (Cyp40), FK506-binding proteins FKBP51 and FKBP52, our team seeks to define critically needed reagents to understand the role of the `large immunophilin' family in neurological disease. We began studies on our recently funded R21 program and have reported signficance success within our initial year of funding.The revenue generated will be used for the latter half of the program. A two year award was provided within this funding period. These funds to cover salaries, research supplies, instrument time, and equipment access to complete these studies.
National Institutes of Health Grant R01CA236352 via a Salk Institute Sub-Award. Studies associated with sub-award associated with NIH grant R01CA236352 were conducted. These studies focused on developing methods for plant natural product production, isolation and structure elucidation. As well as the preparation of probes and synthetic materials. The remaining funds are being used to support the ongoing efforts towards this program.
Varigen Biosciences / Terra Bioworks. Granted funding was provided to support small molecule isolation and structure elucidation efforts. These funds were used to cover research supplies, instrument time, and equipment access to complete these studies. Two publications were published: Pham NT, Alves J, Sargison FA, Cullum R, Wildenhain J, Fenical W, Butler MS, Mead DA, Duggan BM, Fitzgerald JR, La Clair JJ, Auer M. Nanoscaled Discovery of a Shunt Rifamycin from Salinispora arenicola Using a Three-Color GFP-Tagged Staphylococcus aureus Macrophage Infection Assay. ACS Infect Dis. 2023 Aug 11;9(8):1499-1507. Stankey RJ, Johnson D, Duggan BM, Mead DA, La Clair JJ. A Survey of Didemnin Depsipeptide Production in Tistrella. Mar Drugs. 2023 Jan 17;21(2):56. doi: 10.3390/md21020056.
Grant from Metabolon. Funds were provided to guide synthesis of an unknown natural product including providing spectroscopic services. Funds were used to sponsor lecture costs as well as conduct spectroscopic services.

Personnel at Xenobe Research Institute

NameTitleCompensation
James la ClairPresident$44,193

Financials for Xenobe Research Institute

RevenuesFYE 06/2024
Total grants, contributions, etc.$61,315
Program services$0
Investment income and dividends$0
Tax-exempt bond proceeds$0
Royalty revenue$0
Net rental income$0
Net gain from sale of non-inventory assets$0
Net income from fundraising events$0
Net income from gaming activities$0
Net income from sales of inventory$0
Miscellaneous revenues$0
Total revenues$61,315

Form 990s for Xenobe Research Institute

Fiscal year endingDate received by IRSFormPDF link
2024-062025-02-26990View PDF
2024-062024-12-23990View PDF
2024-062024-10-15990View PDF
2023-062025-02-26990View PDF
2023-062023-09-25990View PDF
...and 13 more Form 990s
Data update history
December 6, 2024
Posted financials
Added Form 990 for fiscal year 2024
November 30, 2023
Posted financials
Added Form 990 for fiscal year 2023
November 29, 2023
Updated personnel
Identified 1 new personnel
November 25, 2023
Posted financials
Added Form 990EZ for fiscal year 2022
May 7, 2023
Updated personnel
Identified 1 new personnel
Nonprofit Types
Medical research organizationsResearch centersCharities
Issues
Science and technologyHealth
Characteristics
Conducts researchPartially liquidatedState / local levelReceives government fundingTax deductible donationsNo full-time employeesAccepts online donations
General information
Address
PO Box 3052
San Diego, CA 92163
Metro area
San Diego-Chula Vista-Carlsbad, CA
County
San Diego County, CA
Website URL
xenobe.org/ 
Phone
(858) 401-3083
IRS details
EIN
20-1624945
Fiscal year end
June
Taxreturn type
Form 990
Year formed
2004
Eligible to receive tax-deductible contributions (Pub 78)
Yes
Categorization
NTEE code, primary
H90: Medical Specialty Research
NAICS code, primary
5417: Scientific Research and Development Services
Parent/child status
Independent
California AB-488 details
AB 488 status
May Operate or Solicit for Charitable Purposes
Charity Registration status
Current
FTB status revoked
Not revoked
AG Registration Number
126526
FTB Entity ID
2586336
AB 488 data last updated ("as-of") date
2025-04-16
Free account sign-up

Want updates when Xenobe Research Institute has new information, or want to find more organizations like Xenobe Research Institute?

Create free Cause IQ account